| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 09/18/2002 | EP0893996B1 Use of a rapamycin derivative in vasculopathies and xenotransplantation |
| 09/18/2002 | EP0842161B1 4,5-diaryl oxazole derivatives |
| 09/18/2002 | EP0840604B1 Non-beta-oxidizable fatty acid analogues, their uses as therapeutic active medicaments, and preparation thereof |
| 09/18/2002 | EP0823889B1 1,3-propane diol derivatives as bioactive compounds |
| 09/18/2002 | CN1370238A Human poly(ADP-ribose) polymerase 2 materials and methods |
| 09/18/2002 | CN1370180A Conjugates of phytosterol or phytostanol with ascorbic acid and use thereof in treating or preventing cardiovascular disease |
| 09/18/2002 | CN1370179A Aromatic and heterocyclic derivatives of phytosterols and/or phytosanols for use in treating or preventing cardiovascular disease |
| 09/18/2002 | CN1370175A Dithiepino [6,5-b] pyridines, and related compsns. and methods |
| 09/18/2002 | CN1370173A Isomeric fused pyrrolocarbazoles and isoindolones |
| 09/18/2002 | CN1370168A Novel spiro compounds |
| 09/18/2002 | CN1370167A Bispidine compounds useful in treatment of cardiac arrhythmias |
| 09/18/2002 | CN1370166A Bispidine compounds useful in treatment of cardiac arrhythmias |
| 09/18/2002 | CN1370165A Bispidine compounds useful in treatment of cardiac arrhythmias |
| 09/18/2002 | CN1370164A Bispidine compounds useful in treatment of cardiac arrhythmias |
| 09/18/2002 | CN1370163A Imidazo [1,2-A] pyridine and pyrazolo [2,3-a] pyridine derivatives |
| 09/18/2002 | CN1370159A Indole derivatives and their use for treatment of osteoporosis amongst other applications |
| 09/18/2002 | CN1370154A Aminothiazole derivatives and their use as CRF receptor ligands |
| 09/18/2002 | CN1370152A 5-cyano-2-aminopyrimidine derivatives |
| 09/18/2002 | CN1370147A Novel integrin alpha V\ beta3 inhibitors |
| 09/18/2002 | CN1370146A Alpha/Beta integrin inhibitors |
| 09/18/2002 | CN1370145A Novel process |
| 09/18/2002 | CN1370143A Propanoic acid derivatives that inhibit binding of integrins to their receptors |
| 09/18/2002 | CN1370069A Use of CGRP antagonists and CGRP release inhibitors for controlling menopausal hot flashes |
| 09/18/2002 | CN1370068A Pharmaceutical agent comprising benzamide derivative as active ingredient |
| 09/18/2002 | CN1369492A Non-peptide angiotonin II receptor antagon Jw sartan compounds and its synthesizing process and application |
| 09/18/2002 | CN1369300A Microwave inducing method for extracting action components from Chinese-medicinal materials |
| 09/18/2002 | CN1369298A Capsule for treating hemiplegia and rheumatism |
| 09/18/2002 | CN1369297A 'Sishen Tongmai' mixture and its preparing process |
| 09/18/2002 | CN1369289A Chinese medicine for treating cardiovascular and cerebrovascular diseases and its preparing process |
| 09/18/2002 | CN1369270A Pearl shell capsule and its preparing process |
| 09/18/2002 | CN1090953C Prepn. and use of external-use medicine for cardiac and cerebral vascular diseases and rhematism |
| 09/18/2002 | CN1090947C External application powder compsn. and cloth wetting agent |
| 09/18/2002 | CN1090938C Ointment contg. low-molecular heparm and its preparing method |
| 09/18/2002 | CA2403500A1 Substituted biphenyl derivatives |
| 09/17/2002 | US6452001 1,4-diazepine-2-one derivatives as neurokinin antagonist |
| 09/17/2002 | US6451976 Bi-or multifunctional molecules based on a dendroaspin scaffold |
| 09/17/2002 | US6451859 C16 unsaturated FP-selective prostaglandins analogs |
| 09/17/2002 | US6451842 Cyclic amine derivatives and their use as drugs |
| 09/17/2002 | US6451839 Indole sPLA2 inhibitors |
| 09/17/2002 | US6451838 1-(pyrrolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives |
| 09/17/2002 | US6451834 Indeno[1,2-c]-, naphtho[1,2-c]- and benzo[6,7]cyclohepta[1,2-c]pyrazole derivatives |
| 09/17/2002 | US6451826 Optically pure (−) amlodipine compositions |
| 09/17/2002 | US6451824 Sulfonylaminocarboxylic acids |
| 09/17/2002 | US6451804 Heteroalkylamino-substituted bicyclic nitrogen heterocycles |
| 09/17/2002 | US6451803 N-acyl and n-aroyl aralkyl amides useful in treating seritonergic disorders |
| 09/17/2002 | US6451802 S-oxide lipid lowering compounds |
| 09/17/2002 | US6451794 2,3-Diaryl-pyrazolo[1,5-b]pyridazines derivatives, their preparation and their use as cyclooxygenase 2(COX-2) inhibitors |
| 09/17/2002 | US6451791 Amidoaromatic ring sulfonamide hydroxamic acid compounds |
| 09/17/2002 | US6451786 Tyrosine kinase inhibitors |
| 09/17/2002 | US6451785 Beta lactams as antiproliferative agents |
| 09/17/2002 | US6451783 Administering to an obese patient or a patient at risk of becoming obese therapeutically effective amount of compound that attenuates binding of agouti-related protein to melanocortin receptors |
| 09/17/2002 | US6451764 VEGF-related protein |
| 09/17/2002 | US6451594 Adenovirus vector comprising transgene, cardiomyocyte restricted ankyrin repeat protein promoter, and inverted terminal repeat sequences from human adeno-associated virus |
| 09/17/2002 | US6451534 Kvlqt1 and kcne1 which are genes associated with long qt syndrome. additional sequence data for the two genes are also disclosed. mutations in kvlqt1 which result in long qt syndrome. the intron/exon junction sequence data allow for the |
| 09/17/2002 | US6451522 Combining agent to be tested, antibody or antigen-binding fragment which binds to amino terminal domain of mammalian cc-chemokine receptor 2, mammalian cc-chemokine receptor 2 or ligand-binding variant, measuring binding |
| 09/17/2002 | US6451303 Method for treating a human patient for coronary artery disease, comprising administering into one or more coronary vessels in a human patient in need of treatment for coronary artery disease an effective amount of a recombinant fibroblast |
| 09/17/2002 | CA2243459C Human antibodies that bind human tnf.alpha. |
| 09/17/2002 | CA2180325C Methods of inhibiting angiogenesis and tumor growth, and treating ophthalmologic conditions with angiostatic and therapeutic steroids |
| 09/17/2002 | CA2103805C Use of lacidipine for the treatment of arteriosclerosis |
| 09/17/2002 | CA2048096C N-benzyl-indoles |
| 09/17/2002 | CA2045473C Compositions for treating ischemia-related neuronal damage |
| 09/16/2002 | CA2376844A1 Pyrazolo¢4,3-d!pyrimidin-7-ones and pyrazolo¢3,4!pyrimidin-4-ones and purinones which inhibit cgmp pdes |
| 09/16/2002 | CA2376738A1 Purine derivatives for the treatment of ischemia |
| 09/12/2002 | WO2002070742A1 Method for the development of gene panels for diagnostic and therapeutic purposes based on the expression and methylatoin status of the genes |
| 09/12/2002 | WO2002070741A2 Methods, systems and computer program products for determining the biological effect and/or activity of drugs, chemical substances and/or pharmaceutical compositions based on their effect on the methylation status of the dna |
| 09/12/2002 | WO2002070708A2 Glutamate receptor modulatory proteins and nucleic acids encoding them |
| 09/12/2002 | WO2002070706A2 Interleukin-8 homologous polypeptides and therapeutic uses thereof |
| 09/12/2002 | WO2002070676A2 Use of protein histidine phosphatase |
| 09/12/2002 | WO2002070669A2 Secreted proteins |
| 09/12/2002 | WO2002070565A2 High-affinity antagonists of elr-cxc chemokines |
| 09/12/2002 | WO2002070563A2 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | WO2002070562A2 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | WO2002070561A2 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | WO2002070560A2 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | WO2002070559A2 Nuclear hormone receptor ligand binding domains |
| 09/12/2002 | WO2002070558A2 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | WO2002070557A2 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | WO2002070549A2 Chimeric polypeptides of serum albumin and uses related thereto |
| 09/12/2002 | WO2002070534A1 C2, 8-disubstituted adenosine derivatives and their different uses |
| 09/12/2002 | WO2002070532A2 C2,5'-disubstituted and n6,c2,5'-trisubstituted adenosine derivatives and their different uses |
| 09/12/2002 | WO2002070523A1 Modulators of chemokine receptor activity |
| 09/12/2002 | WO2002070520A1 Substituted 2,6-diamino-3,5-dicyano-4-aryl-pyridines and their use as adenosine receptor-selective ligands |
| 09/12/2002 | WO2002070515A2 Chromane derivatives, process for their preparation and their use as antitumor agents |
| 09/12/2002 | WO2002070514A1 Alkoxycarbonylamino heteroaryl carboxylic acid derivatives as ip antagonists |
| 09/12/2002 | WO2002070511A1 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same |
| 09/12/2002 | WO2002070510A2 Amino dicarboxylic acid derivatives with pharmaceutical properties |
| 09/12/2002 | WO2002070509A2 Antagonists of mcp-1 function and methods of use thereof |
| 09/12/2002 | WO2002070502A1 Dimeric isoflavones |
| 09/12/2002 | WO2002070500A1 Alkoxycarbonylamino benzoic acid or alkoxycarbonylamino tetrazolyl phenyl derivatives as ip antagonists |
| 09/12/2002 | WO2002070496A1 Nitric oxide donors based on metallic centres |
| 09/12/2002 | WO2002070490A1 Agonists of beta-adrenoceptors |
| 09/12/2002 | WO2002070485A1 Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and their use as adenosine receptor-selective ligands |
| 09/12/2002 | WO2002070484A1 Substituted 2-oxy-3,5-dicyano-4-aryl-6-aminopyridines and use thereof |
| 09/12/2002 | WO2002070479A1 N-4-piperidinyl compounds as ccr5 modulators |
| 09/12/2002 | WO2002070478A1 Indolone derivatives having vascular-damaging activity |
| 09/12/2002 | WO2002070473A2 Carboxamide derivatives as therapeutic agents |
| 09/12/2002 | WO2002070471A1 Phenyl derivatives and their use in the treatment of thromboembolic disorders or tumours |
| 09/12/2002 | WO2002070462A1 Substituted amino dicarboxylic acid derivatives |
| 09/12/2002 | WO2002070461A1 Side-chain halogenated amino carboxylic acid derivatives as medicaments for treating cardiovascular diseases |
| 09/12/2002 | WO2002070460A1 Halogen-substituted amino dicarboxylic acid derivatives as medicaments for treating cardiovascular diseases |